Annual Accounts Receivable
$3.55 M
+$2.00 M+128.26%
December 31, 2023
Summary
- As of February 27, 2025, TLSI annual accounts receivable is $3.55 million, with the most recent change of +$2.00 million (+128.26%) on December 31, 2023.
- During the last 3 years, TLSI annual accounts receivable has risen by +$2.20 million (+161.90%).
- TLSI annual accounts receivable is now at all-time high.
Performance
TLSI Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$4.91 M
+$206.00 K+4.38%
September 30, 2024
Summary
- As of February 27, 2025, TLSI quarterly accounts receivable is $4.91 million, with the most recent change of +$206.00 thousand (+4.38%) on September 30, 2024.
- Over the past year, TLSI quarterly accounts receivable has increased by +$1.86 million (+60.94%).
- TLSI quarterly accounts receivable is now at all-time high.
Performance
TLSI Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
TLSI Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +128.3% | +60.9% |
| 3 y3 years | +161.9% | - |
| 5 y5 years | +161.9% | - |
TLSI Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +161.9% | at high | +215.5% |
| 5 y | 5-year | at high | +161.9% | at high | +215.5% |
| alltime | all time | at high | +161.9% | at high | +215.5% |
TriSalus Life Sciences Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.91 M(+4.4%) |
| Jun 2024 | - | $4.71 M(+10.0%) |
| Mar 2024 | - | $4.28 M(+20.3%) |
| Dec 2023 | $3.55 M | $3.55 M(+16.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $3.05 M(+91.7%) |
| Mar 2023 | - | $1.59 M(+2.2%) |
| Dec 2022 | $1.56 M(+14.7%) | $1.56 M |
| Dec 2021 | $1.36 M | - |
FAQ
- What is TriSalus Life Sciences annual accounts receivable?
- What is the all time high annual accounts receivable for TriSalus Life Sciences?
- What is TriSalus Life Sciences annual accounts receivable year-on-year change?
- What is TriSalus Life Sciences quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for TriSalus Life Sciences?
- What is TriSalus Life Sciences quarterly accounts receivable year-on-year change?
What is TriSalus Life Sciences annual accounts receivable?
The current annual accounts receivable of TLSI is $3.55 M
What is the all time high annual accounts receivable for TriSalus Life Sciences?
TriSalus Life Sciences all-time high annual accounts receivable is $3.55 M
What is TriSalus Life Sciences annual accounts receivable year-on-year change?
Over the past year, TLSI annual accounts receivable has changed by +$2.00 M (+128.26%)
What is TriSalus Life Sciences quarterly accounts receivable?
The current quarterly accounts receivable of TLSI is $4.91 M
What is the all time high quarterly accounts receivable for TriSalus Life Sciences?
TriSalus Life Sciences all-time high quarterly accounts receivable is $4.91 M
What is TriSalus Life Sciences quarterly accounts receivable year-on-year change?
Over the past year, TLSI quarterly accounts receivable has changed by +$1.86 M (+60.94%)